Long-term monitoring of rec-GH treatment by serial determination of serum aminoterminal propeptide of type III procollagen in children and adults with GH deficiency

Journal of Endocrinological Investigation

Volumn 22, Issue 3, 1999, Pages 169-175

  Sartorio, Alessandro ^a,c   Arosio, M ^b   Conti, A ^a   Ferrero, S ^a   Porretti, S ^b   Faglia, G ^b  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c IRCCS   (Italy)

Author keywords

Collagen; GH; GH deficiency

Indexed keywords

COLLAGEN; PROCOLLAGEN; RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ADULT; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; COLLAGEN SYNTHESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; EDEMA; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARESTHESIA; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SOFT TISSUE;

EID: 0032924002     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343537     Document Type: Article

References (26)

1. Risteli L., Risteli J. Noninvasive methods for detection of organ fibrosis. In: Rojkind M. (Ed.), Connective tissue in health and disease. CRC Press Inc., Boca Raton, USA, 1990, p. 61.
2. Fessier J.H., Fessier L.I. Biosynthesis of collagen. Annu. Rev. Biochem. 47: 129, 1978.
3. Daughaday W.H. Growth hormone and the somatomedins. In: Daughaday W.H. (Ed.), Endocrine control of growth. Elsevier, New York, 1981, p. 1.
4. Fleischmajer R., Timpl R., Tuderman L., Raisher L., Wiestner M., Perlish J.S., Graves P.N. Ultrastructural identification of extension amino-propeptides of type I and III collagens in human skin. Proc. Natl. Acad. Sci. USA 78: 7360, 1981.
5. Isaksson O.G.P., Eden S., Jansson J.O. Mode of action of pituitary growth hormone on target cells. Annu. Rev. Physiol. 47: 483, 1985.
6. Prockop D.J., Kivirikko K.I., Tuderman L., Guzman N.A. The biosynthesis of collagen and its disorders. N. Engl. J. Med. 301: 13, 1979.
7. Risteli J., Niemi S., Trivedi P., Maentausta O., Mowat A.P., Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin. Chem. 34: 715, 1988.
8. Salmela P.I., Juustila H., Pyhtinen J., Jokinen K., Alavaikko M., Ruokonen A. Effective clinical response to long term octreotide treatment, with reduced serum of growth hormone, insulin-like growth factor-I, and the amino-terminal propeptide of type III procollagen in acromegaly. J. Clin. Endocrinol. Metab. 70: 1193, 1990.
9. Sartorio A., Monzani M., Conti A., Casati G., Faglia G. Serum amino-terminal propeptide of type III procollagen (PIIINP) levels in patients with acromegaly before and after pituitary adenomectomy. Eur. J. Intern. Med. 4: 79, 1993.
10. Piovesan A., Terzolo M., Reimondo G., Pia A., Codegone A., Osella G., Boccuzzi A., Paccotti P., Angeli A. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. Horm. Metab. Res. 26: 234, 1994.
11. Conti A., Sartorio A., Ferrero S., Ferrario S., Ambrosi B. Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy. J. Endocrinol. Invest. 19: 127, 1996.
12. Sartorio A., Conti A., Giambona S., Ferrero S., Re T., Passini E., Ambrosi B. Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma. Eur. J. Endocrinol. 38: 146, 1998.
13. Lindstedt G., Weijkum L., Lundberg P.A., Albertsson-Wikland K. Serum procollagen-III as indicator of therapeutic effect in children treated for somatotropin deficiency. Clin. Chem. 15: 1879, 1984.
14. Tapanainen P., Risteli L., Knip M., Kaar M., Risteli J. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy. J. Clin. Endocrinol. Metab. 67: 1244, 1988.
15. Danne T., Gruters A., Schuppan D., Quantas N., Enders I., Weber B. Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders. J. Pediatr. 114: 257, 1989.
16. Trivedi P., Hindmarsh P., Risteli J., Risteli L., Mowat A.P., Brook C.G.D. Growth velocity, growth hormone therapy, and serum concentrations of the aminoterminal propeptide of type III procollagen. J. Pediatr. 114: 225, 1989.
17. Sartorio A., Conti A., Morabito F., Monzani M., Faglia G. Serum bone Gla protein and aminoterminal propeptide of type III procollagen levels in patients with GH deficiency before and after met-GH treatment. In: Cavallo L., Job J.C., New M.I. (Eds.), Growth disorders: the state of the art. Raven Press, New York, 1991, p. 329.
18. Saggese G., Baroncelli G.I., Bertelloni S., Cinquanta L., Di Nero G. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J. Pediatr. 122: 37, 1993.
19. Vihervuori E., Turpeinen M., Siimes M.A., Koistinen H., Sorva R. Collagen formation and degradation increase during growth hormone therapy in children. Bone 20: 133, 1997.
20. Trivedi P., Risteli J., Risteli L., Hindmarsh P.C., Brook C.G.D., Mowat A.P. Serum concentrations of type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and in children with growth disorders. Pediatr. Res. 30: 276, 1991.
21. Amato G., Carella C., Fazio S., La Montagna G., Cittadini A., Sabatini D., Marciano-Mone C., Saccá L., Bellastella A. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J. Clin. Endocrinol. Metab. 77: 1671, 1993.
22. Sartorio A., Conti A., Monzani M., Morabito F., Faglia G. Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover. J. Endocrinol. Invest. 16: 893, 1993.
23. Bengtsson B.A., Edén S., Lonn L., Kvist H., Stokland A., Lindstedt G., Bosaeus I., Tolli J., Sjostrom L., Isaksson O.G.P. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J. Clin. Endocrinol. Metab. 76: 309, 1993.
24. Sartorio A., Conti A., Monzani M. New markers of bone and collagen turnover in children and adults with growth hormone deficiency. Postgrad. Med. J. 69: 846, 1993.
25. Bergmann P., Valsamis J., Van Perborgh J., De Schepper J., Van Vliet G. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone. J. Clin. Endocrinol. Metab. 71: 1461, 1990.
26. Jensen L.T., Jorgensen J.O.L., Risteli J., Christiansen J.S., Lorenzen I. Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH. Acta Endocrinol. (Copenh.) 724: 278, 1991.